AGP Executive Report
Last update: 3 hours agoDrug Industry: Merck KGaA agreed to buy UK biotech Silence Therapeutics for $1.3 billion, adding gene-silencing treatments for rare diseases to its pipeline. Roche, meanwhile, has put future German investments on hold, citing uncertainty. Manufacturing: Sanofi has broken ground on an insulin plant in Frankfurt, backed by German government support. Public Health: Germany is moving ahead with higher tobacco taxes and a planned sugary-drink tax, aiming to curb health costs and smoking. Infectious Disease: Two locally acquired West Nile virus cases have been reported in southwest Germany. Care and Prevention: Public health insurance contributions are expected to remain stable in 2027, while winter vaccination guidance is drawing attention as flu season approaches.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.